These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17907341)

  • 1. Major patent reform moves closer.
    Hughes B
    Nat Rev Drug Discov; 2007 Sep; 6(9):688-9. PubMed ID: 17907341
    [No Abstract]   [Full Text] [Related]  

  • 2. The coming US patent opposition.
    Apple T
    Nat Biotechnol; 2005 Feb; 23(2):245-7. PubMed ID: 15696151
    [No Abstract]   [Full Text] [Related]  

  • 3. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent US patent legislation: what's new for biotech?
    Gogoris AC; Todaro JC
    Nat Biotechnol; 2000 Feb; 18(2):229-31. PubMed ID: 10657135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. US Patent Office strategic plan may penalize biotechs.
    Robertson D
    Nat Biotechnol; 2003 Apr; 21(4):345-6. PubMed ID: 12665807
    [No Abstract]   [Full Text] [Related]  

  • 6. Inter partes reexamination: a potentially useful approach to challenging invalid biotechnology patents.
    Derzko NM; Behringer JW
    Nat Biotechnol; 2003 Jul; 21(7):823-5. PubMed ID: 12833101
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent reform acts ugly.
    Nat Biotechnol; 2007 Nov; 25(11):1187. PubMed ID: 17989652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EU states back biotech patent reforms.
    Dickson D; Butler D
    Nature; 1993 Dec 23-30; 366(6457):713. PubMed ID: 8264788
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA-based patents: an empirical analysis.
    Mills AE; Tereskerz P
    Nat Biotechnol; 2008 Sep; 26(9):993-5. PubMed ID: 18779808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. India's IP snub.
    Jayaraman KS
    Nat Biotechnol; 2008 Apr; 26(4):362. PubMed ID: 18392000
    [No Abstract]   [Full Text] [Related]  

  • 11. The human use of humanoid beings: chimeras and patent law.
    Rabin S
    Nat Biotechnol; 2006 May; 24(5):517-9. PubMed ID: 16680130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent reform prompts intellectual tug-of-war.
    Nature; 2005 Oct; 437(7063):1230-1. PubMed ID: 16251923
    [No Abstract]   [Full Text] [Related]  

  • 13. US courts narrow patent exemptions.
    Fox JL
    Nat Biotechnol; 2003 Aug; 21(8):834. PubMed ID: 12894182
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotech patents-business as usual?
    Lawrence S
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract]   [Full Text] [Related]  

  • 15. "Ganske" threatens biotechnology patents worldwide.
    Glaser V
    Nat Biotechnol; 1997 Feb; 15(2):121. PubMed ID: 9035128
    [No Abstract]   [Full Text] [Related]  

  • 16. Process patent bill on track.
    Gershon D
    Nature; 1993 Jul; 364(6435):274. PubMed ID: 8332176
    [No Abstract]   [Full Text] [Related]  

  • 17. Biotechnology inventions in the health care environment: what to patent and how to avoid defeat.
    Murashige KR
    Benders Health Care Law Mon; 1995 Dec; ():3-10. PubMed ID: 10158648
    [No Abstract]   [Full Text] [Related]  

  • 18. Court leaves patent issue unclear.
    Marshall E
    Science; 1991 Oct; 254(5030):368. PubMed ID: 1925589
    [No Abstract]   [Full Text] [Related]  

  • 19. Insulin patent dispute revisits old biotechnology battleground.
    Fox JL
    Nat Biotechnol; 1997 Apr; 15(4):307. PubMed ID: 9094114
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical patent life-cycle management after KSR v. Teleflex.
    Furrow ME
    Food Drug Law J; 2008; 63(1):275-320. PubMed ID: 18561462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.